Middle East and Africa Point of Care Testing Market

Middle East and Africa point of care testing market were accounted USD 1.81 billion in 2018 and also it is subjected to grow at a CAGR of 9.32% to reach USD 2.85 billion by 2023. Point of care testing provides instant results with the providers and it is very helpful to diagnose the results and provide immediate treatment for the patient. Some tests can also be done at home at ease by reading the instructions provided on the kits.

Market Dynamics:

• Increasing awareness towards the testing devices and also a growing demand for convenient testing process in patients and doctors are key driving factors for the market. Rise in the investments on the construction of healthcare centers and also improving ambulatory services are also leveling up the demand of the market.
• However, lack of complete knowledge over the utilization of these devices especially in rural areas is limiting the demand of the market. Strict rules and regulations by the government may show a negative impact on the demand of the market.
• Growth opportunities for the market lie in the rising geriatric population and rise in the support from the government by changing schemes in favor of the common people. The rise in the emergence of advanced technology is creating a new chance for the market in the Middle East and Africa.

Blood glucose monitoring testing segment in product type is leading with the highest shares of the market

By product, the market is segmented into blood glucose monitoring testing, infectious disease testing, cardiac metabolic monitoring testing and others. Blood glucose monitoring testing segment is witnessed to have the highest shares of the market. Rising incidences of diabetes are mainly fueling the demand of the market.

Later flow assays type is expected to continue the highest shares of the market throughout the review period

Based on platform type, the market is bifurcated into lateral flow assays, dipsticks, microfluidics, and molecular diagnostics. Lateral flow assays are accounted to have the largest shares of the market. Increasing demand in the molecular diagnostics filed is one of the factors prompting the demand of the market.

Regionally, the Middle East and Africa are accounted to have decent growth and is estimated to have tremendous revenues during the foreseen years by owing to adoption of latest technological developments and rise in awareness towards the testing devices. An increasing number of cancer patients is also boosting up the growth of the market.

Few of the Key Players dominating the Middle East and Africa Point of Care Testing Market Profiled in the Report are:

• Danaher Corporation
• Instrumentation Laboratory SpA
• BioMerieux SA
• Nova Biomedical. F
• Hoffmann-La Roche Ltd.
• Trividia Health Inc.
• Sekisui Diagnostics LLC
• Quidel Corporation
• QIAGEN
• Abbott Laboratories
• Becton Dickinson & Company
• Siemens Healthcare GmbH

This research report includes following segmentation for the Middle East and Africa Point of Care Testing Market size and forecast until 2023.

Middle East and Africa Point of Care Testing Market - By Product

• Blood Glucose Testing Kits
• Cardiometabolic Monitoring Kits
• Pregnancy and Fertility Tests Kits
• Infectious Disease Testing Kits
• Cholesterol Testing Kits
• Tumor/Cancer Markers
• Cholesterol Test Strips
• Urinalysis Testing Kits
• Hematology Testing Kits
• Rapid Coagulation Testing Kits
• Drugs of Abuse Testing Kits
• Fecal Occult Testing Kits
• Others

Middle East and Africa Point of Care Testing Market - By Prescription Mode

• Prescription Based Testing
• Over-The-Counter (OTC) Testing

Middle East and Africa Point of Care Testing Market - By Region

• Middle East
• Africa